Primary |
Atrial Fibrillation |
46.1% |
Hypertension |
16.8% |
Deep Vein Thrombosis |
5.3% |
Prophylaxis |
4.8% |
Thrombosis Prophylaxis |
4.0% |
Myocardial Ischaemia |
3.2% |
Pulmonary Embolism |
2.1% |
Diabetes Mellitus |
1.9% |
Back Pain |
1.6% |
Bronchopneumonia |
1.6% |
Cardiac Failure |
1.6% |
Mitral Valve Replacement |
1.6% |
Cardiac Valve Prosthesis User |
1.3% |
Epilepsy |
1.3% |
Hypertensive Heart Disease |
1.3% |
Anticoagulant Therapy |
1.1% |
Bronchitis |
1.1% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Pneumonia |
1.1% |
Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
|
International Normalised Ratio Increased |
17.8% |
Subdural Haematoma |
9.2% |
Melaena |
8.6% |
Anaemia |
5.9% |
Hypocoagulable State |
5.9% |
Overdose |
5.9% |
Haematoma |
5.3% |
Head Injury |
4.6% |
Renal Failure Acute |
4.6% |
Syncope |
4.6% |
Presyncope |
3.9% |
Rectal Haemorrhage |
3.9% |
Epistaxis |
3.3% |
Vomiting |
3.3% |
Pneumonia |
2.6% |
Toxicity To Various Agents |
2.6% |
Cerebral Haemorrhage |
2.0% |
Injury |
2.0% |
Iron Deficiency Anaemia |
2.0% |
Pallor |
2.0% |
|
Secondary |
Hiv Infection |
20.0% |
Arterial Disorder |
6.7% |
Atrial Fibrillation |
6.7% |
Cardiac Valve Prosthesis User |
6.7% |
Constipation |
6.7% |
Deep Vein Thrombosis |
6.7% |
Embolism Venous |
6.7% |
Hypertension |
6.7% |
Ischaemic Stroke |
6.7% |
Pain |
6.7% |
Pneumonia |
6.7% |
Pulmonary Embolism |
6.7% |
Pyrexia |
6.7% |
|
Pneumonia |
25.0% |
Renal Failure Acute |
25.0% |
Sepsis |
25.0% |
Uterine Disorder |
25.0% |
|
Interacting |
Atrial Fibrillation |
15.4% |
Depression |
15.4% |
Hypertension |
15.4% |
Arrhythmia Prophylaxis |
7.7% |
Bronchitis |
7.7% |
Bronchitis Chronic |
7.7% |
Prophylaxis |
7.7% |
Skin Ulcer |
7.7% |
Thrombosis Prophylaxis |
7.7% |
Type 2 Diabetes Mellitus |
7.7% |
|
Rectal Haemorrhage |
50.0% |
Vertigo |
50.0% |
|